Automated Breast Ultrasound System Market

Automated Breast Ultrasound System Market Forecast and Outlook 2025 to 2035

The global automated breast ultrasound system market is projected to reach USD 1,950.0 million by 2035, recording an absolute increase of USD 970.0 million over the forecast period. The market is valued at USD 980.0 million in 2025 and is set to rise at a CAGR of 7.1% during the assessment period.

The overall market size is expected to grow by nearly 2.0 times during the same period, supported by increasing demand for breast cancer screening technologies worldwide, driving demand for automated diagnostic solutions and increasing investments in women's health and early detection programs globally. However, high system costs and radiologist training requirements may pose challenges to market expansion.

Quick Stats for Automated Breast Ultrasound System Market

• Automated Breast Ultrasound System Market Value (2025): USD 980.0 million
• Automated Breast Ultrasound System Market Forecast Value (2035): USD 1,950.0 million
• Automated Breast Ultrasound System Market Forecast CAGR: 7.1%
• Leading End User in Automated Breast Ultrasound System Market: Hospitals
• Key Growth Regions in Automated Breast Ultrasound System Market: North America, Europe, and Asia Pacific
• Top Key Players in Automated Breast Ultrasound System Market: GE HealthCare, Siemens Healthineers, Canon Medical Systems, Hitachi Healthcare, SonoCiné, Delphinus Medical Technologies, QT Ultrasound, CMR Naviscan, Fujifilm Healthcare, Supersonic Imagine
• Automated Breast Ultrasound System Market Year-over-Year Forecast (2025-2035)

Between 2025 and 2030, the automated breast ultrasound system market is projected to expand from USD 980.0 million to USD 1,395.0 million, resulting in a value increase of USD 415.0 million, which represents 42.8% of the total forecast growth for the decade. This phase of development will be shaped by rising demand for breast cancer screening automation and early detection technologies, product innovation in imaging resolution technologies and AI-enhanced diagnostic capabilities, as well as expanding integration with digital health platforms and telemedicine applications. Companies are establishing competitive positions through investment in advanced imaging technologies, automated analysis systems, and strategic market expansion across hospitals, diagnostic centers, and women's health applications.

From 2030 to 2035, the market is forecast to grow from USD 1,395.0 million to USD 1,950.0 million, adding another USD 555.0 million, which constitutes 57.2% of the overall ten-year expansion. This period is expected to be characterized by the expansion of specialized automated ultrasound technologies, including AI-powered diagnostic systems and personalized screening solutions tailored for specific patient populations, strategic collaborations between imaging equipment manufacturers and healthcare providers, and an enhanced focus on accessibility improvement and cost-effective screening programs. The growing emphasis on preventive healthcare and early cancer detection will drive demand for comprehensive automated breast ultrasound solutions across diverse healthcare settings.

Automated Breast Ultrasound System Market Key Takeaways

Metric	Value
Market Value (2025)	USD 980.0 million
Market Forecast Value (2035)	USD 1,950.0 million
Forecast CAGR (2025-2035)	7.1%

Why is the Automated Breast Ultrasound System Market Growing?

The automated breast ultrasound system market grows by enabling healthcare providers to enhance breast cancer screening while accessing advanced diagnostic capabilities without substantial operator dependency concerns. Radiologists and healthcare facilities face mounting pressure to improve screening accuracy and reduce interpretation variability, with automated breast ultrasound systems typically providing 85-90% higher detection consistency and efficiency compared to traditional manual ultrasound methods, making automated imaging technology essential for comprehensive breast health positioning. The women's health industry's need for standardized screening protocols and application-specific diagnostic accuracy creates demand for automated ultrasound solutions that can provide superior consistency, maintain reliable performance, and ensure reproducible results without compromising diagnostic quality or screening efficiency standards.

Breast cancer awareness and screening program expansion drive adoption in hospitals, diagnostic centers, and women's health clinics, where early detection capabilities have a direct impact on patient outcomes and survival rates. However, system complexity constraints and specialist training requirements may limit rapid implementation among smaller facilities and regions with limited radiology expertise or technical infrastructure for advanced imaging systems.

Segmental Analysis

The market is segmented by end user, technology, and region. By end user, the market is divided into hospitals, diagnostic centers, and others. Based on technology, the market is categorized into 3D and 2D imaging systems. Regionally, the market is divided into North America, Europe, Asia Pacific, and other key regions.

By End User, the Hospitals Segment Accounts for a Dominant Market Share

The hospitals segment represents the dominant force in the automated breast ultrasound system market, capturing approximately 61.0% of total market share in 2025. This established healthcare category encompasses facilities featuring comprehensive diagnostic capabilities and integrated women's health services, including advanced imaging departments and specialized breast care centers that enable superior patient care and diagnostic excellence across all screening conditions. The hospitals segment's market leadership stems from its infrastructure advantages, with facilities capable of supporting complex imaging systems while maintaining consistent diagnostic quality and operational efficiency across all healthcare environments.

The diagnostic centers segment maintains a substantial 29.0% market share, serving patients who require specialized imaging services with dedicated breast screening features for focused diagnostic applications and preventive care programs. These centers offer premium screening solutions for specialized breast health services while providing sufficient diagnostic capabilities to meet outpatient screening and early detection requirements. The others segment accounts for approximately 10.0% of the market, serving women's health clinics, mobile screening units, and specialized breast care facilities.

Key infrastructure advantages driving the hospitals segment include:

• Comprehensive diagnostic capabilities with integrated imaging departments that ensure superior screening coordination while maintaining multidisciplinary care support
• Advanced infrastructure design enabling complex system installation and operational support requirements
• Specialized breast care integration allowing coordinated screening programs and treatment planning
• Enhanced resource efficiency features, supporting high-volume screening and comprehensive patient management per facility

By Technology, the 3D Technology Segment Accounts for the Largest Market Share

3D technology applications dominate the automated breast ultrasound system market with approximately 58.0% market share in 2025, reflecting the advanced imaging capabilities and superior diagnostic accuracy provided by three-dimensional breast imaging systems worldwide.

The 3D technology segment's market leadership is reinforced by enhanced visualization capabilities, improved lesion detection rates, and rising requirements for comprehensive breast tissue evaluation in screening and diagnostic applications across developed and emerging markets.

The 2D technology segment represents the established imaging category, capturing 42.0% market share through cost-effective imaging solutions for basic breast screening, routine diagnostic applications, and budget-conscious healthcare settings. This segment benefits from proven imaging technology that provides reliable screening capabilities, established clinical protocols, and accessible diagnostic solutions in competitive healthcare environments.

Key market dynamics supporting technology growth include:

• 3D technology advancement driven by diagnostic accuracy requirements and increasing demand for comprehensive breast tissue visualization requiring advanced imaging capabilities in healthcare markets
• Enhanced detection capabilities trends require superior imaging resolution for early cancer detection and diagnostic precision
• Integration of advanced imaging technologies enabling comprehensive screening programs and diagnostic optimization systems
• Growing emphasis on screening accuracy driving demand for advanced, reliable 3D imaging solutions without diagnostic limitation susceptibility

What are the Drivers, Restraints, and Key Trends of the Automated Breast Ultrasound System Market?

The market is driven by three concrete demand factors tied to healthcare and diagnostic outcomes. First, breast cancer awareness and screening program expansion create increasing demand for automated diagnostic technologies, with breast cancer screening requirements expanding by 10-15% annually in major developed countries worldwide, requiring comprehensive automated ultrasound infrastructure. Second, healthcare digitization and diagnostic standardization drive increased adoption of automated imaging systems, with many healthcare facilities implementing standardized screening protocols for consistency and efficiency improvement by 2030. Third, technological advancements in AI integration and imaging automation enable more accurate and efficient breast screening solutions that improve detection rates while enhancing workflow efficiency and diagnostic consistency features.

Market restraints include high system costs and capital investment requirements that can limit accessibility for smaller healthcare providers, particularly in developing regions where advanced imaging equipment funding remains constrained and reimbursement coverage may be limited. Training complexity and specialist requirements pose additional challenges, as automated breast ultrasound systems require specialized radiologist training and ongoing system optimization, potentially causing implementation delays and operational complexity. Limited clinical awareness and adoption barriers across different healthcare settings create additional market challenges for system providers, demanding ongoing investment in clinical education and workflow integration support.

Key trends indicate accelerated growth in North American and European markets, where established healthcare infrastructure and breast cancer screening programs drive comprehensive automated ultrasound adoption. Technology integration trends toward AI-powered analysis with machine learning capabilities, cloud-based image storage, and integrated reporting systems enable advanced diagnostic approaches that improve accuracy and minimize interpretation variability. However, the market thesis could face disruption if significant advances in alternative breast imaging technologies or changes in screening guidelines reduce reliance on traditional automated ultrasound systems.

Analysis of the Automated Breast Ultrasound System Market by Key Country

Country	CAGR (2025-2035)
USA	7.8%
Mexico	7.4%
Germany	7.0%
France	6.9%
South Korea	6.7%
UK	6.7%
Japan	6.5%

The automated breast ultrasound system market is gaining momentum worldwide, with the USA taking the lead thanks to advanced healthcare infrastructure and comprehensive breast cancer screening initiatives. Close behind, Mexico benefits from expanding healthcare modernization activities and women's health development programs, positioning itself as a strategic growth hub in the Latin American region. Germany shows strong advancement, where integration of medical imaging technologies strengthens its role in the European diagnostic equipment supply chain. France and the UK are focusing on breast cancer prevention and diagnostic technology innovation initiatives, signaling ambitions to capitalize on growing opportunities in European women's health markets. Meanwhile, South Korea stands out for its healthcare technology adoption in existing medical imaging and diagnostic operations, and Japan continues to record consistent progress in advanced medical imaging equipment modernization. Together, the USA and Mexico anchor the regional expansion story, while the rest build stability and diversity into the market's growth path.

The report covers an in-depth analysis of 40+ countries; 7 top-performing countries are highlighted below.

USA Leads Global Market Expansion

The USA demonstrates the strongest growth potential in the Automated Breast Ultrasound System Market with a CAGR of 7.8% through 2035. The country's leadership position stems from advanced healthcare infrastructure, comprehensive breast cancer screening programs, and women's health initiatives driving the adoption of automated diagnostic technologies. Growth is concentrated in major medical centers and metropolitan healthcare areas, including New York, Los Angeles, Chicago, and Boston, where hospitals and imaging centers implement advanced automated breast ultrasound systems for enhanced screening accuracy and early detection programs. Distribution channels through medical imaging distributors and women's health specialists expand coverage across hospital and diagnostic center applications. The country's established healthcare system provides market support for advanced imaging technology adoption, including AI-enhanced and 3D automated ultrasound systems.

Key market factors:

• Healthcare infrastructure expansion concentrated in metropolitan areas and medical centers with comprehensive women's health programs
• Breast cancer screening advancement through early detection initiatives and preventive care programs
• Comprehensive medical imaging ecosystem, including established diagnostic imaging providers with proven women's health expertise
• Technology integration featuring advanced imaging platforms, AI analysis systems, and digital health technologies

Mexico Emerges as Strong Growth Market

In Mexico City, Guadalajara, Monterrey, and Tijuana, the adoption of automated breast ultrasound solutions is expanding across healthcare facilities and diagnostic centers, driven by healthcare infrastructure development and women's health program expansion. The market demonstrates strong growth momentum with a CAGR of 7.4% through 2035, linked to healthcare system modernization and increasing focus on preventive care solutions. Mexican healthcare facilities are implementing automated breast ultrasound equipment and screening systems to enhance diagnostic capabilities while meeting growing demand in expanding women's health and preventive care sectors. The country's healthcare development programs and medical modernization create sustained demand for advanced imaging equipment, while increasing emphasis on early detection drives adoption of automated screening and diagnostic systems.

• Leading healthcare expansion cities, including Mexico City, Guadalajara, Monterrey, and Tijuana, are driving automated breast ultrasound adoption
• Healthcare modernization development models enabling 50% faster equipment deployment timelines
• Medical facility agreements accelerating installation with international automated breast ultrasound suppliers
• Healthcare policy support through women's health initiatives and preventive care development programs

Germany Maintains Medical Imaging Leadership

Germany's established healthcare sector demonstrates sophisticated implementation of automated breast ultrasound solutions, with documented case studies showing 45% improvement in screening efficiency through advanced imaging system integration. The country's healthcare infrastructure in major cities, including Berlin, Munich, Hamburg, and Frankfurt, showcases integration of medical imaging technologies with existing diagnostic systems, leveraging expertise in precision medical devices and healthcare excellence. German healthcare facilities emphasize quality and accuracy standards, creating demand for high-performance automated breast ultrasound equipment that supports clinical excellence initiatives and patient care requirements. The market maintains strong growth through focus on medical imaging integration and diagnostic excellence, with a CAGR of 7.0% through 2035.

Key development areas:

• Healthcare facilities and imaging centers leading automated breast ultrasound technology adoption with comprehensive modernization programs
• Medical imaging services channels providing integrated solutions with 93% diagnostic accuracy rates
• Technology partnerships between automated breast ultrasound companies and German healthcare providers expanding market reach
• Integration of imaging technologies and comprehensive women's health management systems

France Shows Strong Healthcare Innovation

France's market expansion is driven by diverse healthcare demand, including specialized breast centers in Paris and diagnostic facilities in other major cities, and comprehensive healthcare modernization across multiple regions. The country demonstrates solid growth potential with a CAGR of 6.9% through 2035, supported by healthcare investment programs and women's health development initiatives. French healthcare facilities face implementation challenges related to system costs and training requirements, requiring strategic adoption approaches and support from international suppliers. However, growing preventive care demands and screening program expansion create compelling business cases for automated breast ultrasound adoption, particularly in healthcare centers where early detection capabilities have a direct impact on patient outcomes and clinical competitiveness.

Market characteristics:

• Women's health segment showing consistent growth with 32% annual increase in automated breast ultrasound utilization
• Regional expansion trends focused on healthcare centers and diagnostic imaging facilities
• Future projections indicate need for medical imaging infrastructure and radiology specialist programs
• Growing emphasis on preventive care and early detection positioning in healthcare operations

United Kingdom Demonstrates Healthcare Innovation

The UK market shows strength in women's health innovation based on integration with advanced healthcare systems and diagnostic technologies for enhanced patient outcomes. The country shows strong potential with a CAGR of 6.7% through 2035, driven by the modernization of existing healthcare infrastructure and the expansion of breast screening programs in major areas, including London, Manchester, Birmingham, and Edinburgh. British healthcare facilities are adopting automated breast ultrasound equipment for screening optimization and diagnostic excellence, particularly in regions with established women's health requirements and clinical excellence positioning demanding comprehensive imaging upgrades. Technology deployment channels through established medical imaging suppliers and breast care specialists expand coverage across hospital and diagnostic center applications.

Leading market segments:

• Healthcare modernization projects in major medical centers implementing comprehensive automated breast ultrasound equipment upgrades
• Healthcare partnerships with technology providers, achieving 90% screening efficiency improvement rates
• Strategic collaborations between automated breast ultrasound suppliers and UK healthcare companies expanding market presence
• Focus on clinical excellence positioning and specialized women's health requirements

South Korea Emphasizes Healthcare Technology Integration

In Seoul, Busan, Incheon, and Daegu, healthcare facilities are implementing comprehensive automated breast ultrasound solutions to modernize existing diagnostic infrastructure and improve screening capabilities, with documented case studies showing a 40% improvement in detection accuracy through advanced imaging technologies. The market shows strong growth potential with a CAGR of 6.7% through 2035, linked to ongoing modernization of healthcare facilities, medical technology expansion, and emerging digital health projects in major cities. Korean healthcare companies are adopting automated breast ultrasound and imaging platforms to enhance diagnostic outcomes while maintaining quality standards demanded by the competitive healthcare and medical technology industries. The country's established healthcare infrastructure creates sustained demand for medical imaging upgrade and modernization solutions that integrate with existing diagnostic systems.

Market development factors:

• Healthcare facilities and diagnostic centers leading automated breast ultrasound equipment modernization initiatives across urban areas
• Digital health modernization programs providing investment support for healthcare and imaging infrastructure upgrades
• Strategic partnerships between Korean healthcare companies and international automated breast ultrasound providers expanding technical capabilities
• Emphasis on diagnostic quality and clinical standards compliance across healthcare applications

Japan Emphasizes Precision and Clinical Excellence

Japan's Automated Breast Ultrasound System Market demonstrates sophisticated implementation focused on precision diagnostics and clinical excellence optimization, with documented integration of advanced imaging systems achieving 42% improvement in screening accuracy across healthcare and diagnostic facilities. The country maintains steady growth momentum with a CAGR of 6.5% through 2035, driven by healthcare facilities' emphasis on quality standards and precision methodologies that align with clinical excellence principles applied to women's health operations. Major metropolitan areas, including Tokyo, Osaka, Nagoya, and Fukuoka, showcase advanced deployment of imaging platforms where automated breast ultrasound systems integrate seamlessly with existing healthcare systems and comprehensive patient care programs.

Key market characteristics:

• Healthcare facilities and imaging centers driving precision automated breast ultrasound requirements with emphasis on quality and diagnostic accuracy
• Clinical excellence partnerships enabling 95% system reliability with comprehensive quality assurance programs
• Technology collaboration between Japanese companies and international automated breast ultrasound providers expanding market capabilities
• Emphasis on precision diagnostics requirements and clinical excellence methodologies

Europe Market Split by Country

The automated breast ultrasound system market in Europe is projected to grow from USD 285.0 million in 2025 to USD 570.0 million by 2035, registering a CAGR of 7.2% over the forecast period. Germany is expected to maintain its leadership position with a 25.3% market share in 2025, maintaining 25.0% by 2035, supported by its extensive healthcare infrastructure, advanced medical imaging adoption, and comprehensive women's health networks serving major European markets.

The United Kingdom follows with a 22.8% share in 2025, projected to reach 23.1% by 2035, driven by comprehensive breast screening programs in London, Manchester, and other metropolitan areas implementing advanced diagnostic technologies. France holds a 20.4% share in 2025, expected to maintain 20.1% by 2035 through ongoing development of healthcare facilities and women's health networks. Italy commands a 12.6% share, while Spain accounts for 10.5% in 2025. The Rest of Europe region is anticipated to gain momentum, expanding its collective share from 8.4% to 9.2% by 2035, attributed to increasing automated breast ultrasound adoption in Nordic countries and emerging Eastern European healthcare facilities implementing women's health modernization programs.

Competitive Landscape of the Automated Breast Ultrasound System Market

The Automated Breast Ultrasound System Market features approximately 10-15 meaningful players with moderate concentration, where the top three companies control roughly 55-65% of global market share through established technology portfolios and extensive healthcare industry relationships. Competition centers on imaging accuracy, system reliability, and clinical workflow integration rather than price competition alone.

Market leaders include GE HealthCare, Siemens Healthineers, and Canon Medical Systems, which maintain competitive advantages through comprehensive automated breast ultrasound solution portfolios, global distribution networks, and deep expertise in the medical imaging and women's health sectors, creating strong relationships with hospitals and imaging centers. These companies leverage established healthcare partnerships and ongoing clinical development contracts to defend market positions while expanding into adjacent diagnostic imaging and healthcare technology applications.

Global Automated Breast Ultrasound System Market - Stakeholder Contribution Framework

Automated breast ultrasound system solutions represent a critical women's health technology that enables healthcare providers, radiologists, and screening programs to enhance breast cancer detection and diagnostic consistency without substantial operator dependency concerns, typically providing 85-90% higher detection consistency and efficiency compared to traditional manual ultrasound methods. With the market projected to grow from USD 980.0 million in 2025 to USD 1,950.0 million by 2035 at a 7.1% CAGR, these solutions offer compelling advantages - superior diagnostic consistency, enhanced screening efficiency, and automated analysis capabilities - making them essential for hospital applications (61.0% market share), diagnostic centers (29.0% share), and other healthcare sectors seeking reliable automated breast imaging solutions. Scaling market penetration and imaging capabilities requires coordinated action across healthcare policy, medical imaging standards, equipment manufacturers, healthcare providers, and clinical training institutions.

How Governments Could Spur Local Production and Adoption?

• Women's Health Programs: Include automated breast ultrasound capabilities in national women's health and cancer prevention initiatives, providing targeted funding for screening equipment in healthcare facilities and supporting local technology companies through innovation grants and manufacturing incentives.
• Tax Policy & R&D Support: Implement accelerated depreciation schedules for medical imaging equipment, provide tax incentives for companies investing in diagnostic technologies, and establish favorable research accounting standards that encourage automated screening adoption over manual diagnostic approaches.
• Regulatory Framework Development: Create streamlined certification processes across breast imaging and women's health applications, establish clear diagnostic accuracy frameworks for automated systems, and develop international harmonization protocols that facilitate cross-border medical imaging equipment trade.
• Skills Development & Training: Fund vocational programs for medical imaging technicians, radiologists, and healthcare professionals. Invest in technology transfer initiatives that bridge academic research with commercial automated breast ultrasound development and screening optimization systems.
• Market Access & Competition: Establish procurement policies that favor advanced screening technologies for government healthcare facility applications, support small and medium healthcare providers through preferential reimbursement programs, and create regulatory environments that encourage innovation in women's health technologies.

How Industry Bodies Could Support Market Development?

• Imaging Standards & Certification: Define standardized accuracy metrics for automated breast ultrasound systems across hospital, clinic, and screening applications, establish universal diagnostic quality and safety protocols, and create certification programs for system performance that healthcare providers can trust.
• Market Education & Best Practices: Lead messaging that demonstrates automated breast ultrasound advantages, emphasizing improved screening consistency, enhanced diagnostic efficiency, and superior early detection compared to traditional manual screening methods.
• Technology Integration Standards: Develop interoperability standards for breast imaging systems, healthcare facility compatibility guidelines, and clinical workflow assessment platforms, ensuring consistent screening practices across different healthcare environments and diagnostic requirements.
• Professional Development: Run certification programs for radiologists, imaging technicians, and healthcare teams on optimizing automated breast ultrasound performance, interpretation protocols, and screening quality management in competitive healthcare markets.

How Manufacturers and Medical Imaging Players Could Strengthen the Ecosystem?

• Advanced Imaging Development: Develop next-generation automated breast ultrasound technologies with enhanced accuracy capabilities, improved AI integration, and smart analysis options that enhance diagnostic outcomes while reducing interpretation variability.
• Integration Platforms: Provide comprehensive imaging software that integrates automated analysis, clinical reporting, workflow management, and quality assurance, enabling healthcare providers to maximize screening effectiveness and diagnostic accuracy.
• Support & Service Networks: Offer flexible support programs for healthcare facilities and imaging centers, including training services, technical support options, and clinical optimization pathways that keep imaging systems current with healthcare demands.
• Research & Development Networks: Build comprehensive R&D capabilities, collaborative medical imaging programs, and clinical development systems that ensure automated breast ultrasound systems maintain high performance standards and diagnostic accuracy across diverse healthcare applications.

How Suppliers Could Navigate the Shift?

• Diversified System Portfolios: Expand automated breast ultrasound offerings across 3D imaging (58.0% technology share), 2D systems (42.0% share), and specialty applications, with particular focus on hospital (61.0% end user share) and specialized solutions for diverse screening requirements.
• Geographic Market Development: Establish operations in high-growth markets like the USA (7.8% CAGR) and Mexico (7.4% CAGR), while strengthening presence in established markets like Germany (7.0% CAGR) and France (6.9% CAGR) through regional manufacturing capabilities and healthcare partnerships.
• Technology-Enabled Services: Implement advanced support systems with real-time system monitoring, automated quality control, and predictive maintenance features that differentiate service offerings and improve healthcare provider satisfaction and performance.
• Flexible Business Models: Develop standard, premium, and specialized automated breast ultrasound solutions that accommodate varying healthcare needs, from cost-effective screening applications to high-performance specifications for demanding diagnostic and research requirements.

How Investors and Financial Enablers Could Unlock Value?

• Medical Imaging Technology Expansion Financing: Provide growth capital for established companies like GE HealthCare, Siemens Healthineers, and Canon Medical to expand automated breast ultrasound production capacity and geographic coverage, particularly in emerging markets with growing women's health screening demands.
• Innovation Investment: Back startups developing advanced imaging technologies, AI-powered diagnostic systems, and integrated screening platforms that enhance healthcare industry efficiency and competitive positioning.
• Regional Market Development: Finance market entry and expansion strategies for automated breast ultrasound companies establishing operations in high-growth regions, supporting localization initiatives that reduce system costs while maintaining diagnostic accuracy standards.
• Consolidation & Scale Opportunities: Support strategic acquisitions and market consolidation that create economies of scale, improve imaging capabilities, and enhance competitive positioning against fragmented regional medical imaging providers across multiple geographic markets.

Key Players in the Automated Breast Ultrasound System Market

• GE HealthCare
• Siemens Healthineers AG
• Canon Medical Systems Corporation
• FUJIFILM Healthcare Americas Corporation
• SonoCiné, Inc.
• Delphinus Medical Technologies, Inc.
• QT Imaging, Inc.
• CMR Naviscan Corporation
• FUJIFILM Healthcare
• SuperSonic Imagine (Hologic, Inc.)

Scope of the Report

Item	Value
Quantitative Units	USD 980.0 Million
End User	Hospitals, Diagnostic Centers, Others
Technology	3D, 2D
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country Covered	USA, Germany, France, UK, Japan, South Korea, Mexico, and 40+ countries
Key Companies Profiled	GE HealthCare, Siemens Healthineers, Canon Medical, Hitachi Healthcare, SonoCiné, Delphinus Medical, QT Ultrasound, CMR Naviscan, Fujifilm Healthcare, Supersonic Imagine
Additional Attributes	Dollar sales by end user and technology categories, regional adoption trends across North America, Europe, and Asia Pacific, competitive landscape with automated breast ultrasound manufacturers and healthcare partners, clinical specification requirements and diagnostic standards, integration with women's health initiatives and screening programs, innovations in imaging technology and AI analysis systems, and development of specialized applications with accuracy standards and workflow optimization capabilities.

Automated Breast Ultrasound System Market by Segments

• End User :

  • Hospitals
  • Diagnostic Centers
  • Others

• Technology :

  • 3D
  • 2D

• Region :

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordic
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia & New Zealand
    • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa